UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE Department of Obstetrics, Gynecology and Reproductive Sciences
![REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0891584921007504-gr2.jpg)
REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect
Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-relate
![A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909). - Abstract - Europe PMC A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909). - Abstract - Europe PMC](https://europepmc.org/articles/PMC7859818/bin/atm-09-01-73-f1.jpg)
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909). - Abstract - Europe PMC
![A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA). - Abstract - Europe PMC A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA). - Abstract - Europe PMC](https://europepmc.org/articles/PMC6419339/bin/12885_2019_5446_Fig1_HTML.jpg)
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA). - Abstract - Europe PMC
![REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0891584921007504-gr3.jpg)
REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect
![REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0891584921007504-ga1.jpg)